tiprankstipranks
Argenica Therapeutics Ltd (AU:AGN)
ASX:AGN
Australian Market
Want to see AU:AGN full AI Analyst Report?

Argenica Therapeutics Ltd (AGN) Financial Statements

14 Followers

Argenica Therapeutics Ltd Financial Overview

Argenica Therapeutics Ltd's market cap is currently AU$22.48M. The company's EPS TTM is AU$-0.0761; its P/E ratio is -16.04; Argenica Therapeutics Ltd is scheduled to report earnings on February 10, 2026, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 26Jun 25Jun 24Jun 23Jun 22
Income Statement
Total RevenueAU$ 0.00AU$ 3.21MAU$ 2.60MAU$ 1.75MAU$ 259.10K
Gross ProfitAU$ 0.00AU$ 3.21MAU$ 2.60MAU$ 1.75MAU$ 259.10K
Operating IncomeAU$ -7.06MAU$ -7.68MAU$ -5.67MAU$ -6.62MAU$ -4.09M
EBITDAAU$ -7.06MAU$ 0.00AU$ -1.90MAU$ -4.81MAU$ -4.09M
Net IncomeAU$ -1.37MAU$ -7.17MAU$ -5.48MAU$ -4.82MAU$ -4.09M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 6.36MAU$ 10.56MAU$ 15.91MAU$ 9.34MAU$ 8.91M
Total AssetsAU$ 6.52MAU$ 11.04MAU$ 16.38MAU$ 9.54MAU$ 9.04M
Total DebtAU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Net DebtAU$ -6.36MAU$ -10.56MAU$ -15.91MAU$ -9.29MAU$ -8.91M
Total LiabilitiesAU$ 614.55KAU$ 3.80MAU$ 2.43MAU$ 1.87MAU$ 735.91K
Stockholders' EquityAU$ 5.90MAU$ 7.24MAU$ 13.95MAU$ 7.67MAU$ 8.31M
Cash Flow
Free Cash FlowAU$ 0.00AU$ -5.70MAU$ -5.06MAU$ -3.30MAU$ -3.36M
Operating Cash FlowAU$ -4.19MAU$ -5.70MAU$ -5.06MAU$ -3.30MAU$ -3.36M
Investing Cash FlowAU$ 0.00AU$ 0.00AU$ 50.00KAU$ -50.00KAU$ 0.00
Financing Cash FlowAU$ -2.94KAU$ 346.90KAU$ 11.63MAU$ 3.73MAU$ 5.13M
Currency in AUD

Argenica Therapeutics Ltd Earnings and Revenue History

Argenica Therapeutics Ltd Debt to Assets

Argenica Therapeutics Ltd Cash Flow

Argenica Therapeutics Ltd Forecast EPS vs Actual EPS